Merck Up Nearly 5%, on Track for Record High Close — Data Talk
Merck & Co., Inc. (MRK) is currently at $131.57, up $6.05 or 4.82%
--Would be new all-time high (Based on available data back to Jan. 21, 1972)
--On pace for largest percent increase since April 28, 2022, when it rose 4.94%
--Currently up six of the past seven days
--Currently up four consecutive days; up 6.43% over this period
--Longest winning streak since Feb. 16, 2024, when it rose for four straight trading days
--Best four day stretch since the four days ending Jan. 5, 2024, when it rose 7.52%
--Up 3.48% month-to-date
--Up 20.68% year-to-date
--Up 25.4% from 52 weeks ago (March 29, 2023), when it closed at $104.92
--Would be a new 52-week closing high
--Up 31.33% from its 52-week closing low of $100.18 on Nov. 28, 2023
--Traded as high as $133.10; new all-time intraday high (Based on available data back to Jan. 21, 1972)
--Up 6.04% at today's intraday high; largest intraday percent increase since Oct. 28, 2021, when it rose as much as 6.52%
--Best performer in the DJIA today
--Sixth best performer in the S&P 500 today
--Contributed 39.63 points to the DJIA so far today
All data as of 2:14:35 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 27, 2024 14:31 ET (18:31 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise